Table 3. Number of risk alleles and breast cancer risk for (a) 10a SNP analysis and (b) 7b SNP analysis.
Cases
|
Controls
|
OR (95% CI) | OR (95% CI) | |||
---|---|---|---|---|---|---|
No. of risk alleles | N | % | N | % | Breast cancer | Breast cancer |
(a) | ||||||
Reference=8 risk allelesc | Reference ⩽6 risk alleles | |||||
⩽6 | 521 | 14.5 | 983 | 19.4 | 0.80 (0.69–0.92) | 1 |
7 | 494 | 13.8 | 831 | 16.4 | 0.90 (0.77–1.04) | 1.12 (0.96–1.31) |
8 | 641 | 17.9 | 966 | 19.1 | 1 | 1.25 (1.08–1.45) |
9 | 662 | 18.5 | 873 | 17.2 | 1.14 (0.99–1.32) | 1.43 (1.24–1.66) |
10 | 555 | 15.5 | 682 | 13.5 | 1.23 (1.06–1.42) | 1.54 (1.32–1.79) |
⩾11 | 711 | 19.8 | 728 | 14.4 | 1.47 (1.27–1.70) | 1.84 (1.59–2.14) |
P-trend: 5.6 × 10−20 | ||||||
(b) | ||||||
Reference=5 risk allelesc | Reference ⩽3 risk alleles | |||||
⩽3 | 438 | 12.2 | 916 | 18.1 | 0.67 (0.58–0.78) | 1 |
4 | 539 | 15.0 | 929 | 18.3 | 0.81 (0.71–0.94) | 1.21 (1.04–1.42) |
5 | 759 | 21.2 | 1065 | 21.0 | 1 | 1.49 (1.29–1.73) |
6 | 723 | 20.2 | 963 | 19.0 | 1.05 (0.92–1.20) | 1.57 (1.35–1.82) |
7 | 586 | 16.4 | 659 | 13.0 | 1.25 (1.08–1.44) | 1.86 (1.59–2.18) |
⩾8 | 539 | 15.0 | 531 | 10.5 | 1.42 (1.22–1.66) | 2.12 (1.80–2.50) |
P-trend: 1.5 × 10−25 |
Abbreviations: CI=confidence interval; OR=odds ratio; SNP=single-nucleotide polymorphism.
rs2981582, rs3803662, rs889312, rs13281615, rs3817198, rs981782, rs13387042, rs4666452, rs30099 and rs1045485.
rs2981582, rs3803662, rs889312, rs13281615, rs3817198, rs981782 and rs13387042
Median number of risk alleles.